MARKET

CANF

CANF

Can-Fite BioPharma Ltd.
AMEX
3.310
-0.090
-2.65%
After Hours: 3.230 -0.08 -2.42% 19:34 07/20 EDT
OPEN
3.420
PREV CLOSE
3.400
HIGH
3.420
LOW
3.220
VOLUME
162.75K
TURNOVER
--
52 WEEK HIGH
21.00
52 WEEK LOW
2.560
MARKET CAP
7.09M
P/E (TTM)
-0.0018
1D
5D
1M
3M
1Y
5Y
1D
Can-Fite’s Namodenoson Pancreatic Cancer Data Accepted for ESMO 2026 Presentation
TipRanks · 17h ago
Can-Fite Pancreatic Cancer Data Accepted For ESMO Presentation, To Present Namodenoson Cancer Study Results At The Event
Benzinga · 17h ago
Weekly Report: what happened at CANF last week (0713-0717)?
Weekly Report · 18h ago
Can-Fite Positive Phase 2a Pancreatic Cancer Study Data Accepted for Presentation at ESMO Congress 2026, One of the World's Premier Scientific Meetings in Oncology
Barchart · 22h ago
Can-Fite BioPharma Wins Australian Patent Backing Namodenoson in Liver and Pancreatic Cancer
TipRanks · 6d ago
Can-Fite BioPharma secures Australian Patent Office allowance for namodenoson
TipRanks · 6d ago
Weekly Report: what happened at CANF last week (0706-0710)?
Weekly Report · 07/13 09:37
Can-Fite Completes Key Phase 3 Psoriasis Enrolment Milestone for Piclidenoson
TipRanks · 07/06 11:27
More
About CANF
Can Fite Biopharma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.

Webull offers Can Fite Biopharma Ltd stock information, including AMEX: CANF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CANF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CANF stock methods without spending real money on the virtual paper trading platform.